{{protocol1="/styling"}}

‍

Stem cell therapy for stroke involves using stem cells to treat the effects of a stroke and promote recovery. This therapy aims to replace damaged brain tissue and support the restoration of lost brain function. While there have been many promising studies regarding stem cell therapy for stroke, there are still limitations, and ongoing research is needed to understand the potential benefits and limitations of this treatment fully.

One focus of stem cell-based therapy for stroke is using mesenchymal stem cells (MSCs). MSCs are a type of stem cell found in many different tissues in the body and can potentially differentiate into other cell types, including neurons. MSCs have been studied for their potential to treat neurological disorders, including ischemic brain injury, acute ischemic stroke, hemorrhagic stroke, and chronic stroke. They have shown promising results in preclinical and early clinical studies.

In this article, we will focus on the use of MSCs for treating stroke, including an overview of the benefits and limitations of this therapy and the latest research and developments in this field.

‍

How Does Stem Cell Therapy Work for Stroke Patients?

Stem cell therapy for stroke is a promising new treatment option being explored to help patients recover from the debilitating effects of a stroke. Clinical outcomes have been exciting, and stem cells may offer an attractive new treatment to promote recovery.

The basic idea behind this therapy is to use stem cells to reduce neuroinflammation to help regenerate damaged brain tissue and neural cells lost due to a stroke. Stem cells can also differentiate into different types and replace damaged cells in the human body, making them ideal candidates for regenerative medicine.

‍

Stem cells have several benefits

According to a 2021 study - mesenchymal stem cells (MSCs) possess several benefits, including being immune-privileged, simple to obtain, capable of being stored for an extended period, and conveniently managed. Additionally, using MSCs in a clinical setting does not raise ethical concerns. While growing evidence supports using MSCs in stroke treatment, challenges still must be addressed.

Our review analyzed the safety and efficacy of MSCs in treating both ischemic and hemorrhagic strokes. Stem cell research has found that MSC therapy has demonstrated promising results in some neurological function tests in preclinical trials. However, further research is needed, as there is currently no large-scale clinical trial with randomized, double-blind, and multi-center designs to confirm its effectiveness. (2)

‍

{{protocol2="/styling"}}

‍

How Stem Cells May Help in Stroke Recovery

When a stroke occurs, blood flow to the brain is disrupted, leading to the death of neurons. This can result in various symptoms, including weakness or paralysis on one side of the body, difficulty speaking, and memory problems. Stem cell therapy has the potential to help patients recover from the effects of a stroke by repairing damaged brain tissue and reducing inflammation.

‍

MSCs are believed to release growth factors that help to stimulate the growth and differentiation of surrounding cells, reducing inflammation and promoting neuroregeneration. Also, MSCs have been shown to migrate to areas of injury in the brain, where they can help promote healing and reduce oxidative stress.

‍

In preclinical studies, MSCs effectively reduce brain damage and promote functional recovery after a stroke. These results are promising, but further clinical trials are needed to determine the safety and efficacy of stem cell therapy for stroke patients.

‍

Therapeutic mechanisms of stem cells

Using mesenchymal stem cells (MSCs) for treating stroke is promising due to their unique capabilities. As pluripotent stem cells with a high capacity for self-renewal and the ability to differentiate into various cell types, including adipocytes, chondrocytes, osteoblasts, neurons, and glial cells, MSCs have the potential to play a therapeutic role in stroke treatment. (4)

‍

‍

What Type of Stem Cells are Used to Treat Strokes?

Stem cells are a promising option in the treatment of stroke. Several types of stem cells have been studied for their potential in stroke recovery. However, mesenchymal stem cells (MSCs) have gained significant attention.

Mesenchymal stromal cells are a type of adult stem cell that can be found in bone marrow stromal cells, umbilical cord tissue, and adipose tissue (fat). They have the unique property of differentiating into various types of cells, including cells that can repair damaged tissues. This makes them an ideal candidate for treating stroke, where the goal is to regenerate damaged neurons.

Studies have found that preclinically, MSC therapy was associated with significant benefits for multiple motor and neurological function measures. Clinically, MSC therapy appeared to be safe, with no increase in adverse events reported. (4)

‍

{{stroke="/styling"}}

‍

Mesenchymal stromal cells (MSCs) are safe

Compared to other types of stem cells, such as embryonic stem cells, MSCs have several advantages. They are easier to obtain and can be harvested from the patient’s body, reducing the risk of rejection. They are also more versatile, as they can differentiate into multiple types of cells, including cells that can improve blood flow and reduce inflammation.

Mesenchymal stem cells are a promising type of stem cell for treating stroke. Their ability to differentiate into multiple types of cells, as well as their ease of procurement and low risk of rejection, make them a valuable option for stroke patients.

‍

Can Induced Pluripotent cells be used to treat stroke?

Yes, induced pluripotent stem cells (iPSCs) can potentially be used for stroke treatment. iPSCs are generated from mature cells, such as skin or blood cells. They are reprogrammed to have the properties of embryonic stem cells, including the ability to differentiate into various types of cells, including neural cells.

This makes iPSCs a promising tool for regenerating damaged tissue in the brain after a stroke. However, more research is needed to determine the safety and efficacy of iPSCs for stroke treatment in humans. There have not yet been any large-scale clinical trials to demonstrate their effectiveness.

‍

How Much Does Stem Cell Therapy Cost for Stroke?

The cost of stem cell treatments for stroke can vary depending on factors such as the type of stem cell used, the stroke's severity, the treatment center's location, and the medical staff's expertise. Generally, stem cell therapy for stroke is considered an experimental treatment and is not covered by most insurance plans.

‍

Factors that Affect the Cost of Mesenchymal Stem Cell Therapy for Stroke

Several factors, including the source of the stem cells, the method of extraction, and the medical staff's expertise, can influence the cost of mesenchymal stem cell therapy for stroke. In some cases, the price may also be impacted by the number of treatments required and the extent of the stroke.

‍

Comparison of the Cost of Mesenchymal Stem Cell Therapy with Other Stroke Treatments

The cost of mesenchymal stem cell therapy for stroke can be higher than other traditional stroke treatments, such as physical therapy, rehabilitation, and medication. However, it is essential to remember that mesenchymal stem cell therapy results can be long-lasting and may help improve stroke survivors' overall quality of life. As with any medical treatment, it is best to consult a doctor to determine your situation's best course of action.

‍

{{data="/styling"}}

‍

How Long Does Stem Cell Therapy Last?

Stem cell therapy for stroke involves using stem cells to repair or replace damaged brain tissue caused by the stroke. One of the questions that many stroke survivors and their families have is how long the effects of stem cell therapy can last.

The durability of stem cell therapy for stroke varies and depends on several factors, including the severity of the stroke, the patient's age, overall health, and other underlying medical conditions. In general, the effects of stem cell therapy are long-lasting and may provide benefits for an extended period.

‍

Mesenchymal stem cell therapy for stroke is a newer treatment option with promising results. This type of stem cell therapy can last for an extended period and may provide benefits for several years after the initial treatment. It is important to note that mesenchymal stem cells are not a cure for stroke but can help improve the patient's overall quality of life and function.

‍

Compared to other stroke treatments, such as physical therapy and rehabilitation, mesenchymal stem cell therapy tends to have a longer duration of effect. However, it is essential to note that the time of stem cell therapy can vary from patient to patient, and more research is needed to determine the long-term effects of this treatment.

‍

How do You Qualify for Stem Cell Therapy?

Stem cell therapy for stroke is a relatively new treatment option and is still considered experimental in many cases. The eligibility criteria for stem cell therapy for stroke vary based on several factors, including the type of stem cells used, the stroke's severity, and the patient's overall health.

‍

Explanation of How to Qualify for Mesenchymal Stem Cell Therapy for Stroke

To qualify for mesenchymal stem cell therapy, patients must have stable medical conditions, be able to travel internationally, be free of any active cancers or infections, and have access to their diagnosis and medical history. Other eligibility criteria may include the type of stroke, the size and location of the affected area of the brain, and the age and overall health of the patient.

‍

{{apply2="/styling"}}

‍

Comparison of the Qualification Criteria for Mesenchymal Stem Cell Therapy with Other Stroke Treatments

The qualification criteria for mesenchymal stem cell therapy for stroke are generally more relaxed than other treatments such as surgery or physical therapy. However, it is essential to note that not all patients may be eligible for mesenchymal stem cell therapy, and it is best to consult a doctor to determine eligibility.

‍

Does Stem Cell Therapy Cure Paralysis from Stroke?

Stroke can cause severe brain damage, leading to permanent paralysis in some patients. Stem cell therapy for stroke is being researched as a potential cure for paralysis caused by stroke. There is evidence that mesenchymal stem cells, when transplanted into the brain, may help to regenerate damaged brain tissue and promote functional recovery in stroke patients.

In clinical studies, mesenchymal stem cells have been shown to improve blood flow, reduce inflammation, and promote the growth of new blood vessels in the brain, which can lead to improved neurological function. These findings have led to human clinical trials to determine mesenchymal stem cell therapy's long-term safety and efficacy for stroke.

‍

Limitations and Challenges

While stem cell therapy has shown promise in reversing paralysis caused by stroke, many limitations and challenges still need to be addressed. The safety and efficacy of stem cell therapy are still being evaluated in clinical trials, and more research is required to determine the long-term effects of stem cell transplantation.

Additionally, there is a lack of standardization in stem cell therapy. Many types of stem cells are being studied for stroke treatment, including bone marrow-derived cells, human neural stem cells, human embryonic stem cells, and mesenchymal stem cells derived from umbilical cord tissue.

‍

Another challenge is ensuring the transplanted stem cells reach the damaged brain tissue and integrate with the surrounding cells. The location, size, and severity of the brain lesion and the timing of the stroke onset can also impact the effectiveness of stem cell therapy.

‍

Overall, while stem cell therapy holds promise for reversing paralysis caused by stroke, it is still in the early stages of development. Much more research is needed to understand its potential as a cure for paralysis fully.

‍

Study Analysis: Can stem cells help stroke victims?

Stem cells have a naturally regenerative and anti-inflammatory effect, seeking out damaged tissue in the body. For this reason, Stanford University School of Medicine turned to stem cells for clinical trials in healing stroke victims of different ages, anywhere from 6 months to 3 years after their stroke had occurred. The problem included 18 individuals, an average age of 61, who used stem cell transplant therapy directly to the brain. 

The stem cells in the study are derived from donor bone marrow. Within months, all participants showed signs of improved motor function. The patients showed an average increase of 11.4 points on the Fugl-Meyer Assessment, a stroke-specific impairment test, and the results held for years after treatment as monitored by the university.

This trial made tremendous strides in proving that stem cells could effectively treat stroke symptoms years after a patient’s stroke occurrence, and could also be effective at any age.

‍

‍

Stem cell therapy for stroke study

A new study by Michael Levy and colleagues found the intravenous injection of allogeneic mesenchymal stem cells to be a safe and effective treatment option for post-stroke long-term recovery.  

The randomized, placebo-controlled study, published by the University of California, enrolled 36 subjects who had experienced an Ischemic stroke >6 months before the date of study enrollment. The study criteria also required that patients have no substantial improvement in neurological or functional status for two months before study enrollment. 

The safety portion of the study was split into two parts, each increasing the cell dosage upon completion of previous findings. The maximum dosage was 150 million mesenchymal stem cells, per the studies part 1 results of established safety with 1.5 million cells/kg of body weight. The parent cell bank was tested for quality control, including; cell count, viability (are the cells alive), appearance, and viruses. According to Michael Levy and colleagues:

“The primary study endpoint was safety and tolerability, evaluated in all subjects who received any portion of an infusion, and determined by the incidence/severity of adverse events, clinically significant changes on laboratory and imaging tests, vital signs, and physical plus neurological examinations. Four secondary endpoints were scored serially to derive preliminary estimates of efficacy: National Institutes of Health Stroke Scale, Barthel Index (BI), Mini-Mental Status Exam, and Geriatric Depression Scale. For each, the change from baseline was evaluated using Wilcoxon signed-rank test, with primary analysis of preliminary efficacy being change from baseline to 6 months post-infusion, and analysis including all subjects who received an infusion except for one subject who failed to return after the day ten visit for all visits (except for month nine follow-up).” (1)

‍

{{apply="/styling"}}

‍

What is a stroke?

A stroke occurs when the brain is temporarily deprived of oxygen due to an interruption of blood flow. Strokes affect nearly 795,000 people annually in the United States and can strike at any age.

Until recently, only very little could be done to prevent brain damage due to stroke if not caught early and given treatment within hours of its occurrence. However, recent studies and clinical trials with stem cells conducted on real stroke victims have shown excellent results.

‍

What causes a Stroke?

 A stroke can be caused by a loss of blood supply to the brain (ischemic) or a hemorrhage (bleeding within the brain).

‍

‍

What is an Ischemic Stroke?

Other types of strokes, called ischemic strokes, are caused by small obstructions in the blood vessel. These can often be pieces of plaque or blood clots. Ischemic strokes account for nearly 87 percent of all strokes annually. In either case, the interruption of blood flow to the brain causes neurons to die within minutes, possibly leading to lasting brain injury and neurological issues.

Until now, standard treatments, such as tissue plasminogen activators (tPA), were used to dissolve the blood clot. If not administered within hours of the stroke, they are mostly ineffective at preventing lasting disability.

‍

How Long Does it Take for the Brain Stem to Heal After a Stroke?

The time it takes for the brain stem to heal after a stroke can vary, depending on various factors such as the severity of the stroke, the location of the injury, and the individual's overall health. The healing process can be slow and may take months or even years to recover fully. However, various treatments and therapies, such as stem cells and physical therapy, may help promote functional recovery and speed up healing.

‍

The Role of Stem Cells in Brain Stem Healing

Stem cells have the unique property of differentiating into different cell types, including neurons. After a stroke, the brain stem can suffer damage, and stem cells have the potential to help heal this damage. Research has shown that stem cell therapy can promote functional recovery in stroke patients by replacing damaged neurons and promoting the growth of new brain tissue.

‍

Other Factors that Affect Brain Stem Healing After a Stroke

Aside from stem cell therapy, several other factors can influence the healing of the brain stem after a stroke. These include the severity of the stroke, the age of the patient, and the overall health of the patient. Other factors include physical therapy, medications, and other treatments to help with stroke recovery.

Additionally, the timing of treatment after a stroke is vital in terms of the brain stem's ability to heal. The earlier treatment is initiated, the more likely the brain stem will be able to recover from the damage caused by the stroke. This highlights the importance of seeking medical attention as soon as possible after the onset of stroke symptoms.

‍

Can You Regain Brain Cells After a Stroke?

The potential for regaining brain cells after a stroke depends on several factors, including the extent of the damage, the type of stroke, and the speed at which medical attention is received. While the human brain is capable of a process known as neuroplasticity, which allows it to compensate for lost or damaged cells by creating new connections between surviving neurons, the extent of recovery can vary greatly.

‍

‍

The Potential of Stem Cell Therapy to Regenerate Neurons

Stem cell therapy holds promise to regenerate neurons damaged by a stroke. Mesenchymal stem cells, in particular, have shown promise in promoting functional recovery and reducing brain damage after a stroke. These cells have been shown to release growth factors that promote the growth of new blood vessels, reduce inflammation, and help repair damaged brain tissue.

‍

Other Methods for Reversing Brain Cell Damage After a Stroke

Other than stem cell therapy, there are other methods for reversing brain cell damage after a stroke. Physical therapy and rehabilitation can help improve the function of surviving brain cells and promote plasticity. In some cases, medications and surgical interventions may also remove blood clots or restore blood flow to the brain. However, these methods may not lead to the actual regrowth of new brain cells.

‍

Can Stroke Be Cured Permanently?

No, stroke cannot be cured permanently with current medical treatments. The prognosis of stroke depends on various factors, such as the severity of the stroke, the part of the brain affected, and the age and overall health of the patient. While some people can fully recover with proper rehabilitation, others may experience permanent brain damage, leading to long-term physical, cognitive, or emotional impairments.

Stem cell therapy and other medical treatments can help improve stroke recovery by reducing inflammation, promoting neurogenesis, and restoring blood flow to the affected brain areas. However, the complete cure for stroke remains a subject of ongoing research and development.

‍

Factors that Determine the Prognosis of Stroke

The prognosis of stroke, or the likelihood of recovery, is determined by several factors, including the severity of the stroke, the age and overall health of the patient, and the timeliness of treatment. Other factors that can impact the stroke's prognosis include the stroke's location within the brain, the type of stroke (ischemic or hemorrhagic), and the presence of underlying health conditions.

‍

{{strokeapply="/styling"}}

‍

The Limitations of Current Stroke Treatment

While advances in medical technology have led to improved stroke treatments, including rehabilitation and medication, a cure for stroke does not currently exist. Although stem cell therapy shows promise for stroke treatment, further research is needed to determine its efficacy and safety for widespread use. Additionally, even with current treatments, many stroke patients experience long-term symptoms, such as paralysis, speech and language problems, and cognitive impairment. As a result, the search for a cure for stroke remains a top priority in medicine.

‍

What are the Latest Treatments for Stroke?

The latest treatments for stroke include advancements in stem cell therapy and other emerging treatment options. Stem cell therapy involves using stem cells to promote functional recovery and regenerate damaged brain cells.

‍

Other emerging treatments for stroke include physical therapy, cell replacement and transplant, and new pharmaceutical interventions. Additionally, there has been recent research into using umbilical cord blood and adipose tissue to treat stroke. The most effective treatment option may vary depending on the severity of stroke symptoms, the type of stroke (ischemic or hemorrhagic), and individual patient factors.

‍

Advancements in Stem Cell Therapy for Stroke

Stem cell therapy is a rapidly evolving field in the treatment of stroke. Recent advancements have led to the development of new methods for delivering stem cells to the affected brain area, including cell transplantation and in vitro expansion. Some of the latest research has shown promise in using mesenchymal stem cells derived from adipose tissue, bone marrow, and umbilical cord blood to promote functional recovery and reduce stroke symptoms.

‍

Other Emerging Stroke Treatment Options

In addition to stem cell therapy, other emerging stroke treatment options include physical therapy, magnetic resonance imaging, and mouse stroke models for testing new treatments. These new treatments aim to reduce brain damage and improve the prognosis for stroke victims by replacing or repairing damaged neural and neuronal cells in the central nervous system.

Clinical trials and studies are underway to assess these new treatments' safety and efficacy and determine the optimal dose, timing, and delivery methods to achieve the best possible outcomes for stroke patients. As our understanding of the causes of stroke and the mechanisms of recovery continue to grow, so will the development of new and innovative treatments to combat this devastating disease.

‍

Conclusion

In conclusion, mesenchymal stem cell treatment is promising for treating stroke and its associated symptoms. Using mesenchymal stem cells has been shown to promote functional recovery and reduce brain damage in stroke patients. These cells can be sourced from various sources, such as bone marrow, adipose tissue, or umbilical cord blood, and can be used for cell transplantation to help regenerate damaged brain cells.

However, it is essential to note that mesenchymal stem cell therapy is still in its early stages, and there is a need for more research and clinical trials to understand its benefits and limitations fully. Despite this, early clinical trials and animal studies have shown promising results. Mesenchymal stem cell therapy is becoming increasingly popular as a stroke treatment option compared to other stem cell types and treatments.

Overall, while mesenchymal stem cell therapy may not cure stroke, it holds tremendous potential as a treatment option to improve recovery and reduce the impact of stroke on a patient's quality of life. Further research is necessary to fully understand the potential of this promising field in regenerative medicine.

‍

References

1. David C Hess, Lawrence R Wechsler, Wayne M Clark, Sean I Savitz, Gary A Ford, David Chiu, Dileep R Yavagal, Ken Uchino, David S Liebeskind, Alexander P Auchus, Souvik Sen, Cathy A Sila, Jeffrey D Vest, Robert W Mays. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomized, double-blind, placebo-controlled, phase 2 trial. The Lancet Neurology, 2017; DOI: 10.1016/S1474-4422(17)30046-7
2. Li W, Shi L, Hu B, Hong Y, Zhang H, Li X, Zhang Y. Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges. Front Cell Neurosci. 2021 Feb 9;15:628940. doi: 10.3389/fncel.2021.628940. PMID: 33633544; PMCID: PMC7899984.
3. Zhang Y, Dong N, Hong H, Qi J, Zhang S, Wang J. Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke. Int J Mol Sci. 2022 Feb 25;23(5):2550. doi: 10.3390/ijms23052550. PMID: 35269692; PMCID: PMC8910569.
4. Lalu, M.M., Montroy, J., Dowlatshahi, D. et al. From the Lab to Patients: a Systematic Review and Meta-Analysis of Mesenchymal Stem Cell Therapy for Stroke. Transl. Stroke Res. 11, 345–364 (2020). https://doi.org/10.1007/s12975-019-00736-5